title: Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC).
abstract: A variety of therapeutic options are now available for advanced renal cell cancer, including antiangiogenic and anti-mTOR agents. Allogeneic hematopoietic stem cell transplantation, through its graft-versus-tumor effect, can induce clinical responses and prolonged survival in selected cytokine-refractory patients. However, the still relevant transplant-related mortality due to toxicity and graft-versus-host disease is an obstacle to its widespread use.
authors.affiliation: Department of Hematology, Istituto Scientifico San Raffaele, Milano, Italy.
authors.forename: Marco
authors.initials: M
authors.lastname: Bregni
authors.forename: Fabio
authors.initials: F
authors.lastname: Ciceri
authors.forename: Jacopo
authors.initials: J
authors.lastname: Peccatori